LD-2 disclosure · 4th Quarter - Termination (No Activity)
EBITDA CAPITAL
Coverage · No income or expenses were reported on this filing.
Client
- Name
- EBITDA CAPITAL
- Description
- Work with FDA for treatment approval
- Location
- California · United States of America
Registrant
- Description
- Defence finding
- Location
- Stevensville, Maryland, United States of America
